The Role of RICTOR Amplification in Targeted Therapy and Drug Resistance

Molecular Medicine - United States
doi 10.1186/s10020-020-0146-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Role of P53 in Cancer Drug Resistance and Targeted Chemotherapy

Oncotarget
Oncology
2016English

Dissecting Mechanisms of Resistance to Targeted Drug Combination Therapy in Human Colorectal Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

Activation of the Met Kinase Confers Acquired Drug Resistance in FGFR-targeted Lung Cancer Therapy

Oncogenesis
Cancer ResearchMolecular Biology
2016English

Targeted Therapy and Personalized Medicine in Gastrointestinal Stromal Tumors: Drug Resistance, Mechanisms, and Treatment Strategies

OncoTargets and Therapy
OncologyPharmacology
2019English

The Role of Ubiquitination in Tumorigenesis and Targeted Drug Discovery

Signal Transduction and Targeted Therapy
Cancer ResearchGenetics
2020English

Drug Resistance in Cancer Therapy

Drug Delivery and Translational Research
Pharmaceutical Science
2011English

Recent Progress in Mitochondria-Targeted Drug and Drug-Free Agents for Cancer Therapy

Cancers
Cancer ResearchOncology
2019English

Current Trends in Targeted Therapy for Drug-Resistant Infections

Applied Microbiology and Biotechnology
Applied MicrobiologyBiotechnologyMedicine
2019English

The Use of Nanoparticle-Mediated Targeted Gene Silencing and Drug Delivery to Overcome Tumor Drug Resistance

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy